| Tadalafil improves L-NG-nitroarginine methyl ester-induced preeclampsia with fetal growth restriction-like symptoms in pregnant mice K Yoshikawa, T Umekawa, S Maki, M Kubo, M Nii, K Tanaka, H Tanaka, ... American Journal of Hypertension 31 (1), 89-96, 2018 | 46 | 2018 |
| Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes M Kubo, T Umekawa, Y Maekawa, H Tanaka, M Nii, N Murabayashi, ... Journal of Obstetrics and Gynaecology Research 43 (2), 291-297, 2017 | 38 | 2017 |
| Safety and dose‐finding trial of tadalafil administered for fetal growth restriction: a phase‐1 clinical study M Kubo, H Tanaka, S Maki, M Nii, N Murabayashi, K Osato, Y Kamimoto, ... Journal of Obstetrics and Gynaecology Research 43 (7), 1159-1168, 2017 | 36 | 2017 |
| Safety evaluation of tadalafil treatment for fetuses with early-onset growth restriction (TADAFER): results from the phase II trial S Maki, H Tanaka, M Tsuji, F Furuhashi, S Magawa, MK Kaneda, M Nii, ... Journal of clinical medicine 8 (6), 856, 2019 | 35 | 2019 |
| Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions R Tachibana, T Umekawa, K Yoshikawa, T Owa, S Magawa, F Furuhashi, ... Scientific reports 9 (1), 234, 2019 | 30 | 2019 |
| Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report M Sakamoto, K Osato, M Kubo, M Nii, H Tanaka, N Murabayashi, ... Journal of Medical Case Reports 10, 1-5, 2016 | 19 | 2016 |
| Management of pregnancy complicated with intracranial arteriovenous malformation S Katsuragi, J Yoshimatsu, H Tanaka, K Tanaka, M Nii, T Miyoshi, R Neki, ... Journal of Obstetrics and Gynaecology Research 44 (4), 673-680, 2018 | 18 | 2018 |
| Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique M Nii, M Ishida, K Dohi, H Tanaka, E Kondo, M Ito, H Sakuma, T Ikeda Journal of Cardiovascular Magnetic Resonance 20 (1), 52, 2018 | 17 | 2018 |
| Treatment using tadalafil for severe pre‐eclampsia with fetal growth restriction H Tanaka, M Kubo, M Nii, S Maki, T Umekawa, T Ikeda Journal of Obstetrics and Gynaecology Research 43 (7), 1205-1208, 2017 | 14 | 2017 |
| Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial F Furuhashi, H Tanaka, S Maki, M Tsuji, S Magawa, MK Kaneda, M Nii, ... The Journal of Maternal-Fetal & Neonatal Medicine 34 (22), 3709-3715, 2021 | 11 | 2021 |
| A literature review of herpes simplex virus hepatitis in pregnancy S Magawa, H Tanaka, F Furuhashi, S Maki, M Nii, K Toriyabe, T Ikeda The Journal of Maternal-Fetal & Neonatal Medicine 33 (10), 1774-1779, 2020 | 11 | 2020 |
| Evaluation of placental oxygenation in fetal growth restriction using blood oxygen level-dependent magnetic resonance imaging S Magawa, M Nii, N Enomoto, S Takakura, S Maki, H Tanaka, M Ishida, ... Placenta 126, 40-45, 2022 | 10 | 2022 |
| Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort study M Morikawa, S Matsunaga, S Makino, Y Takeda, H Hyoudo, M Nii, ... International Journal of Hematology 114, 18-34, 2021 | 10 | 2021 |
| Evaluation of placental oxygenation index using blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) during normal late pregnancy S Magawa, M Nii, M Ishida, S Takase, R Nakayama, N Enomoto, ... The Journal of Maternal-Fetal & Neonatal Medicine 35 (25), 5274-5281, 2022 | 9 | 2022 |
| Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb) S Maki, H Tanaka, S Takakura, M Nii, K Tanaka, T Ogura, M Kotera, ... BMJ open 12 (6), e054925, 2022 | 9 | 2022 |
| Maternal blood concentration of tadalafil and uterine blood flow in pregnancy H Tanaka, S Maki, S Magawa, M Nii, K Tanaka, K Ikemura, K Toriyabe, ... Medicina 55 (10), 708, 2019 | 9 | 2019 |
| TADAFER II: Tadalafil treatment for fetal growth restriction-a study protocol for a multicenter randomised controlled phase II trial T Umekawa, S Maki, M Kubo, H Tanaka, M Nii, K Tanaka, K Osato, ... BMJ open 8 (10), e020948, 2018 | 9 | 2018 |
| Evaluation of the tolerability of monoclonal antibody therapy for pregnant patients with COVID‐19 S Magawa, M Nii, S Maki, N Enomoto, S Takakura, Y Maegawa, K Osato, ... Journal of Obstetrics and Gynaecology Research 48 (9), 2325-2333, 2022 | 8 | 2022 |
| A retrospective cohort study using a national surveillance questionnaire to investigate the characteristics of maternal venous thromboembolism in Japan in 2018 M Morikawa, T Adachi, A Itakura, M Nii, Y Nakabayashi, T Kobayashi BMC Pregnancy and Childbirth 21, 1-10, 2021 | 8 | 2021 |
| Capacity of Japanese institutions to manage obstetrical disseminated intravascular coagulation in 2018: A national surveillance questionnaire and retrospective cohort study M Morikawa, M Nii, Y Nakabayashi, A Itakura, T Kobayashi, T Adachi Journal of Obstetrics and Gynaecology Research 47 (9), 3159-3170, 2021 | 8 | 2021 |
